|
× |
|
A Meta-Analysis of the Risk of Acute Extrapyramidal Symptoms With Intramuscular Antipsychotics for the Treatment of Agitation PDF |
$40.00 |
|
$40.00 |
|
× |
|
The Vasopressin V1b Receptor Antagonist SSR149415 in the Treatment of Major Depressive and Generalized Anxiety Disorders: Results From 4 Randomized, Double-Blind, Placebo-Controlled Studies PDF |
$40.00 |
|
$40.00 |
|
× |
|
A 7-Week, Randomized, Double-Blind Trial of Olanzapine/Fluoxetine Combination Versus Lamotrigine in the Treatment of Bipolar I Depression PDF |
$40.00 |
|
$40.00 |
|
× |
|
Impact of the COVID-19 Pandemic on Child and Adolescent Psychiatric Emergencies PDF |
$40.00 |
|
$40.00 |
|
|